QI
TCON

QS Investors’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History

QS Investors’s Portfolio TCON Stock Details TCON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$284K Hold
2,185
– – ﹤0.01% 958
2021
Q1 		$360K Buy
+2,185
New +$421K ﹤0.01% 915

Other funds holding TCON

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

QS Investors's TCON Position: Q2 2021 in Review

QS Investors held its TRACON Pharmaceuticals, Inc. Common Stock (TCON) position steady in Q2 2021 at 2,185 shares worth $284K. The position accounts for ﹤0.01% of the portfolio, ranked #958.

QS Investors first reported a position in TCON in Q1 2021 and has held it in 2 quarters since. The position peaked at $360K in Q1 2021. 44 funds tracked by Wall St. Rank hold TCON as of Q2 2021.

  • QS Investors held 2,185 shares of TRACON Pharmaceuticals, Inc. Common Stock worth $284K as of Q2 2021.
  • QS Investors left its TRACON Pharmaceuticals, Inc. Common Stock share count unchanged in Q2 2021.
  • TRACON Pharmaceuticals, Inc. Common Stock made up ﹤0.01% of QS Investors's portfolio in Q2 2021, its #958 holding.
  • QS Investors first reported a position in TRACON Pharmaceuticals, Inc. Common Stock in Q1 2021 and has held it in 2 quarters since.
  • QS Investors's TRACON Pharmaceuticals, Inc. Common Stock position peaked at $360K in Q1 2021.
  • 44 funds tracked by Wall St. Rank held TRACON Pharmaceuticals, Inc. Common Stock as of Q2 2021.

Based on QS Investors's 13F filing for Q2 2021, filed 13 Aug 2021.